Fig. 3From: Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patientsFinal structured plan of the organizational phase of the TDM-based ECPA program. Two complementary pathways were identified: the laboratory pathway (in green, points 1–7), the MD clinical pharmacologist pathway (in red, points 8–14)Back to article page